Understanding the click method PDL has become aware of a number of adverse events and health consequences from the popularised method of OZEMPIC® (semaglutide) administration known as “counting clicks”. OZEMPIC solution is available in pre-filled multidose pens in 1.5mL and 3mL sizes for subcutaneous administration. Both pens contain semaglutide 1.34mg/mL. OZEMPIC dosing is once weekly, starting at 0.25mg, increasing to 0.5mg after 4 weeks, and to 1mg weekly as prescribed. OZEMPIC dosing is achieved by turning the dose selector on the device until the counter displays either 0.25mg or…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Share this article

Related Practice Alerts

Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Is this the right jab? A vaccination service reminder
20 November 2025
NationalDispensingProfessional activitiesVaccination
Learn more
2024-2025 most reported medicines
8 October 2025
National
Learn more